Michael Benkowitz - May 6, 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
PRESIDENT AND COO
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
May 6, 2024
Transactions value $
-$3,130,162
Form type
4
Date filed
5/7/2024, 04:30 PM
Previous filing
Jan 3, 2023
Next filing
Aug 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $5.26M +32.2K +1249.51% $163.30 34.8K May 6, 2024 Direct F1, F2
transaction UTHR Common Stock Disposed to Issuer -$8.39M -32.2K -92.59% $260.51 2.58K May 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -32.2K -100% $0.00* 0 May 6, 2024 Common Stock 32.2K $163.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Includes 118, 113, and 111 shares of common stock acquired on March 4, 2022, March 3, 2023, March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan.